Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Consumers

  • Print
  • Share
  • E-mail
-

Opportunities for Input/Comment to FDA

 

Subscribe to FDA Updates

  • FDA CardioBeat - FDA's Cardiovascular Disease e-mail list delivers updates on safety and regulatory issues related to cardiovascular disease, including product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances.
  • Patient Network News - A twice monthly newsletter containing FDA-related information on a variety of topics, including new product approvals, significant labeling changes, safety warnings, public meetings, and more.
  • MedWatch E-list - Clinically important medical product safety alerts, delivered via e-mail and/or SMS text messages.
-

Advisory Committee Meetings and Public Meetings

Advisory Committees provide FDA with independent opinions and recommendations from outside experts on FDA policies and applications to market new drugs, medical devices, and biologics. Advisory Committees that discuss cardiovascular-related issues include:

-
-
-
-
-